STVNNYSESurgical & Medical Instruments & Apparatus
Stevanato Group S.p.A.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 4, 2026
$19.02+0.12 (+0.63%)
Close on Oct 19, 2026
Share price
−$5.42 (−22.18%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
Stevanato Group S.p.A. grew revenue 7.4% to €1.19B over fiscal 2025. Operating income rose 23.4% to €198.80M, moving the operating margin from 14.6% to 16.8%. Free cash flow was €22.32M.
Revenue
€1.19B
+7.4% vs. a year earlier
Operating income
€198.80M
+23.4% vs. a year earlier
Free cash flow
€22.32M
FY2025
EPS, diluted
0.51 EUR
+18.6% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- €1.19B
- Net income
- €139.84M
- EPS, diluted
- 0.51 EUR
- Free cash flow
- €22.32M
Valuation needs the share price. It fills in once daily prices are connected and converted from EUR.
Eight years at a glance
Fiscal years 2018 to 2025, EUR
Revenue
€1.19B+7.4% YoY
Gross profit
€343.88M+13.7% YoY
Operating income
€198.80M+23.4% YoY
Net income
€139.84M+18.7% YoY
EPS, diluted
0.51 EUR+18.6% YoY
Free cash flow
€22.32M
Reported period